Pfizer and biontech announce an agreement with u.s. government for up to 600 million doses of mrna-based vaccine candidate against sars-cov-2

Pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced the execution of an agreement with the u.s. department of health and human serv

BNTX Ratings Summary

BNTX Quant Ranking